UBS logo

UBS

UBS | NYSE
Chart Builder DCF Calculator
$47.61
-$0.70 (-1.45%)
At close: Nov 16, 2026, 4:00 PM ET
$47.61
$0.00 (0.00%)
After-hours: Nov 16, 2026, 4:00 PM ET
-1.45%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 16, 2026
50
Fundamentals Average
Market Sentiment Neutral
Moat Narrow
Sector Rank #719/1269 (Top 57%)

Why Price Moved

10 days ago
-2.03%

The stock is down amid renewed tensions between UB...

Key Statistics

Market Data

Market Cap $145.77B
1D Range
47.56 48.47
52W Range
36.41 55.72

Valuation (TTM)

PE 16.36
PB 1.65
EV/EBITDA 6.31

Valuation (NTM)

Forward PE 13.13
Forward PEG 0.35
Price Target $22.45
Loading financial charts...

Profile

UBS Group AG, a financial services giant headquartered in Zurich, Switzerland, since its founding in 1862 (and known as UBS AG until its name change in December 2014), delivers a comprehensive range o...

Employees 103,177
IPO Date May 16, 2000
Website www.ubs.com
Fiscal Year January - December

Latest News

TI CEO Haviv Ilan to speak at UBS investor conference

12 hours ago · prnewswire.com

TI CEO Haviv Ilan to speak at UBS investor conference
Septerna, Inc. (SEPN) Presents at UBS Global Biopharma Conference 2026 Transcript

12 hours ago · seekingalpha.com

Septerna, Inc. (SEPN) Presents at UBS Global Biopharma Conference 2026 Transcript
ADARx Pharmaceuticals, Inc. (ADRX) Presents at UBS Global Biopharma Conference 2026 Transcript

12 hours ago · seekingalpha.com

ADARx Pharmaceuticals, Inc. (ADRX) Presents at UBS Global Biopharma Conference 2026 Transcript
Jade Biosciences, Inc. (JBIO) Presents at UBS Global Biopharma Conference 2026 Transcript

13 hours ago · seekingalpha.com

Jade Biosciences, Inc. (JBIO) Presents at UBS Global Biopharma Conference 2026 Transcript
Thermo Fisher Scientific to Participate in UBS 2026 CEO Call Series on November 19, 2026

3 days ago · businesswire.com

Thermo Fisher Scientific to Participate in UBS 2026 CEO Call Series on November 19, 2026
UBS Thinks Rivian Stock Can Hit $17. Is It a Buy?

3 days ago · fool.com

UBS Thinks Rivian Stock Can Hit $17. Is It a Buy?
UBS Announces Redemption of Ten ETNs

4 days ago · businesswire.com

UBS Announces Redemption of Ten ETNs
Chime to Participate in UBS Global Technology and AI Conference

4 days ago · businesswire.com

Chime to Participate in UBS Global Technology and AI Conference
Royalty Pharma to present at the UBS Global Biopharma Conference

4 days ago · globenewswire.com

Royalty Pharma to present at the UBS Global Biopharma Conference
Rivian Just Earned a Buy Rating. Is Wall Street Seeing a Turning Point?

4 days ago · fool.com

Rivian Just Earned a Buy Rating. Is Wall Street Seeing a Turning Point?

Earnings

Latest Earnings
Oct 28, 2026
EPS
$0.85
Miss -6.59%
REV
$13.39B
Beat +2.41%
Next Earnings
Feb 3, 2027
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

Analyst Summary

# of Analysts
2
Consensus
Hold
Price Target
$22.45
Downside
-52.85%
Buy (1)
Hold (1)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.